Multiple infliximab biosimilar switches: results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111, in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry

H Nabi, B Glintborg, A G Loft, O Hendricks, J K Pedersen, S A Just, R Ahmed, K Danebod, H L Munk, A Colic, A Linauskas, D V Jensen, L B Christensen, N Manilo, N Lomborg, S Kristensen, F Mehnert, N S Krogh, M L Hetland

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Rheumatology
Vol/bind50
Udgave nummerSuppl. 130
Sider (fra-til)14-15
Antal sider2
ISSN0300-9742
StatusUdgivet - aug. 2021
Begivenhed38th Scandinavian Congress of Rheumatology - Scandic Parken, Ålesund, Norge
Varighed: 1 sep. 20214 sep. 2021
Konferencens nummer: 38

Konference

Konference38th Scandinavian Congress of Rheumatology
Nummer38
LokationScandic Parken
Land/OmrådeNorge
ByÅlesund
Periode01/09/202104/09/2021

Citationsformater